1. Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir med. 2008;102:399-406. https://doi.org/10.1016/j.rmed.2007.10.012.
2. Soriano JB, Abajobir AA, Abate KH, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Respiratory Medicine. 2017;5(9):691-706. https://doi.org/10.1016/S2213-2600(17)30293-X.
3. Jang JH, Ryu SD, Kim HS, Lee KM, Jung SP. Association between physical activity and hypertension in chronic obstructive pulmonary disease. Korean J Health Promot. 2016;16(2):77-83. https://doi.org/10.15384/kjhp.2016.16.2.77.
4. Crook S, Büsching G, Keusch S, et al. The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease. Intern J Chron Obstruct Pulmon Dis. 2018;13:2199-206. https://doi.org/10.2147/copd.s156986.
5. Tiemensma J, Gaab E, Voorhaar M, Asijee G, Kaptein AA. Illness perceptions and coping determine quality of life in COPD patients. Intern J Chron Obstruct Pulmon Dis. 2016;11:2001-7. https://doi.org/10.2147/copd.s109227.
6. Higginson I. Measuring quality of life: Using quality of life measures in the-NCBI. BMJ. 2001;322(7297):1297-300. https://doi.org/10.1136/bmj.322.7297.1297.
7. Costa HS, Lima MMO, Figueiredo PHS, Chaves AT, Nunes MCP, da Costa Rocha MO. The prognostic value of health-related quality of life in patients with Chagas heart disease. Qual Life Res. 2019;28(1):67-72. https://doi.org/10.1007/s11136-018-1980-7.
8. Yoo KH, Kim YS, Sheen SS, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology. 2011;16(4):659-65. https://doi.org/10.1111/j.1440-1843.2011.01951.x.
9. Ofir D, Laveneziana P, Webb KA, Lam Y-M, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(6):622-9. https://doi.org/10.1164/rccm.200707-1064OC.
10. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171-8. https://doi.org/10.1016/S0140-6736(09)61298-8.
11. Brandl M, Böhmer MM, Brandstetter S, et al. Factors associated with generic health-related quality of life (HRQOL) in patients with chronic obstructive pulmonary disease (COPD): a cross-sectional study. J Thorac Dis. 2018;10(2):766. https://doi.org/ 10.21037/jtd.2018.01.122.
12. Dürr S, Zogg S, Miedinger D, Steveling EH, Maier S, Leuppi JD. Daily physical activity, functional capacity and quality of life in patients with COPD. COPD. 2014;11(6):689-96. https://doi.org/10.3109/15412555.2014.898050.
13. Razzaque A, Nahar L, Akter Khanam M, Kim Streatfield, P. Socio-demographic differentials of adult health indicators in Matlab, Bangladesh: self-rated health, health state, quality of life and disability level. Glob Health Action. 2010;3(1):4618. https://doi.org/10.3402/gha.v3i0.4618.
14. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-68. https://doi.org/10.1183/09031936.05.00035205.
15. Chen J, Wong CK, McGhee SM, Pang PK, Yu WC. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). PLoS One. 2014;9(11):e112389. https://doi.org/10.1371/journal.pone.0112389.
16. Kim MH, Cho YS, Uhm WS, Kim S, Bae SC. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Llife Res. 2005;14(5):1401-6. https://doi.org/10.1007/s11136-004-5681-z.
17. Kim SJ, Han K-T, Lee SY, Park E-C. Quality of life correlation with socioeconomic status in Korean hepatitis-B patients: a cross sectional study. Health and quality of life outcomes. 2015;13(1):1-12. https://doi.org/10.1186/s12955-015-0251-3.
18. Hajian-Tilaki K, Heidari B, Hajian-Tilaki A. Are gender differences in health-related quality of life attributable to sociodemographic characteristics and chronic disease conditions in elderly people? Int J Pev Med. 2017;8:95. https://doi.org/10.4103/ijpvm.IJPVM_197_16.
19. Miravitlles M, Naberan K, Cantoni J, Azpeitia A. Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration. 2011;82(5):402-8. https://doi.org/10.1159/000328766.
20. Zhang Y, Ou F, Gao S, Gao Q, Hu L, Liu Y. Effect of low income on health-related quality of life: a cross-sectional study in northeast China. Asia Pac J Public Health. 2015;27(2): NP1013-NP1025. https://doi.org/10.1177/1010539513496839.
21. Pezeshki M, Rostami Z. Contributing factors in health-related quality of life assessment of ESRD patients: a single center study. Nephro-Urology Monthly. 2009;1(2):129-36.
22. Busutil R, Espallardo O, Torres A, Martínez-Galdeano L, Zozaya N, Hidalgo-Vega Á. The impact of obesity on health-related quality of life in Spain. Health Qual Life Outcomes. 2017;15(1):1-11. https://doi.org/10.1186/s12955-017-0773-y.
23. Becoña E, Vázquez MI, Fernández del Río E, et al. Smoking habit profile and health-related quality of life. Psicothema. 2013;25(4):421-6.
https://doi.org/10.7334/psicothema2013.73.
24. Dai H, Jia G, Liu K. Health-related quality of life and related factors among elderly people in Jinzhou, China: a cross-sectional study. Public Health. 2015;129(6):667-73. https://doi.org/10.1016/j.puhe.2015.02.022.
25. Hong JY, Kim SY, Chung KS, et al. Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D. Qual Life Res. 2015;24(10):2549-58. https://doi.org/10.1007/s11136-015-0979-6.
26. Purba FD, Hunfeld JA, Iskandarsyah A, et al. Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS One. 2018;13(5):e0197098. https://doi.org/10.1371/journal.pone.0197098.
27. Bentsen SB, Rokne B, Wahl AK. Comparison of health‐related quality of life between patients with chronic obstructive pulmonary disease and the general population. Scand J Caring Sci. 2013;27(4):905-12. https://doi.org/10.1111/scs.12002.
28. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004;164(9):1010-4. https://doi.org/10.1001/archinte.164.9.1010.
29. daCosta DiBonaventura M, Paulose-Ram R, Su J, et al. The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. COPD. 2012;9(1):46-57. https://doi.org/10.3109/15412555.2011.634863.
30. Huber MB, Kurz C, Kirsch F, Schwarzkopf L, Schramm A, Leidl R. The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data. Respir Res. 2020;21(1):1-10.
https://doi.org/10.1186/s12931-020-01556-0.
31. Cao C, Wang R., Wang H., Bunjhoo Y, Xu H, Xiong W. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PloS one. 2012;7(8):e43892. https://doi.org/10.1371/journal.pone.0043892.
32. Chan SM, Selemidis S, Bozinovski S, Vlahos R. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacology & therapeutics. 2019;198:160-88.
https://doi.org/10.1016/j.pharmthera.2019.02.013.
33. Wang R, Zhao Y, He X, et al. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public health. 2009;123(8):534-9.
https://doi.org/10.1016/j.puhe.2009.06.009.
34. Wijnhoven H, Kriegsman D, Hesselink A, De Haan M, Schellevis F. The influence of comorbidity on health-related quality of life in asthma and COPD patients. Respir Med. 2003;97(5):468-75. https://doi.org/10.1053/rmed.2002.1463.
35. Van Helvoort HA, Willems LM, Dekhuijzen PR, Van Hees HW, Heijdra YF. Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study. NPJ primary care respiratory medicine. 2016;26(1):1-7. https://doi.org/10.1038/npjpcrm.2016.54.
36. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Internal Med. 2005;142(4):233-9. https://doi.org/10.7326/0003-4819-142-4-200502150-00005.
37. Tønnesen, P. Smoking cessation and COPD. Eur Respir Rev. 2013;22(127):37-43. https://doi.org/10.1183/09059180.00007212.
38. Mun SY, Hwang YI, Kim JH, et al. Awareness of chronic obstructive pulmonary disease in current smokers: a nationwide survey. Korean J Intern Med. 2015;30(2):191-7. https://doi.org/10.3904/kjim.2015.30.2.191.
39. Seo JY, Hwang YI, Mun SY, et al. Awareness of COPD in a high risk Korean population. Yonsei Med J. 2015;56(2):362-7. https://doi.org/10.3349/ymj.2015.56.2.362.
40. Wacker ME, Hunger M, Karrasch S, et al. Health-related quality of life and chronic obstructive pulmonary disease in early stages–longitudinal results from the population-based KORA cohort in a working age population. BMC Pulm Med. 2014;14(1):1-12. https://doi.org/ 10.1186/1471-2466-14-134.